TY - JOUR
AB - Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the western blotting data shown in Figs. 1C and 6D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that some of the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors agree with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 33: 774‑782, 2015; DOI: 10.3892/or.2014.3623]
AD - Center for Reproductive Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
AU - Pan,Yuan
AU - Zhang,Liqun
AU - Zhang,Xinyue
AU - Liu,Ruizhi
DA - 2021/09/01
DO - 10.3892/or.2021.8149
IS - 3
JO - Oncol Rep
KW - ovarian cancer
co-expression plasmid
gene silencing
STAT 3
LK B1
PY - 2021
SN - 1021-335X
1791-2431
SP - 198
ST - [Retracted] Synergistic effects of eukaryotic co‑expression plasmid‑based STAT3‑specific siRNA and LKB1 on ovarian cancer in vitro and in vivo
T2 - Oncology Reports
TI - [Retracted] Synergistic effects of eukaryotic co‑expression plasmid‑based STAT3‑specific siRNA and LKB1 on ovarian cancer in vitro and in vivo
UR - https://doi.org/10.3892/or.2021.8149
VL - 46
ER -